These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3090587)

  • 1. Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP).
    Cunningham KA; Carroll BA; Appel JB
    Psychopharmacology (Berl); 1986; 89(1):134-5. PubMed ID: 3090587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
    Cunningham KA; Appel JB
    J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
    Cunningham KA; Appel JB
    Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of FR-40 by 5-HT agonists. II. Effects of chronic phenelzine or isocarboxazid.
    Shukla R; Goudreau J; Mackenzie-Taylor D; Rech RH
    Pharmacol Biochem Behav; 1989 Oct; 34(2):283-7. PubMed ID: 2622983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.
    Callahan PM; Appel JB
    Psychopharmacology (Berl); 1990; 100(1):13-8. PubMed ID: 2296621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):617-24. PubMed ID: 3211970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behaviorally induced sensitivity to the discriminable properties of LSD.
    Greenberg I; Kuhn DM; Appel JB
    Psychopharmacologia; 1975 Sep; 43(3):229-32. PubMed ID: 1187955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFMPP may produce its stimulus effects via a 5-HT1B mechanism.
    McKenney JD; Glennon RA
    Pharmacol Biochem Behav; 1986 Jan; 24(1):43-7. PubMed ID: 3945665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
    Lucki I; Ward HR; Frazer A
    J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding.
    Nielsen EB; Ginn SR; Cunningham KA; Appel JB
    Behav Brain Res; 1985 Aug; 16(2-3):171-6. PubMed ID: 2931089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal stress prevents the desensitization of the corticosterone response to TFMPP by desmethylimipramine, but not by phenelzine, in adult male offspring.
    Poland RE; Lutchmansingh P; McGeoy S; Au D; Que M; Acosta S; Edelstein M; McCracken JT
    Life Sci; 1995; 57(23):2163-70. PubMed ID: 7475968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; StaroĊ„ J; Nikiforuk A
    J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants.
    Lucki I; Frazer A
    Psychopharmacology (Berl); 1982; 77(3):205-11. PubMed ID: 6812141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD.
    Young R; Rosecrans JA; Glennon RA
    Life Sci; 1982 Jun; 30(24):2057-62. PubMed ID: 7109835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC; Eckler JR; Rabin RA
    Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.